Осложнения со стороны сердечно-сосудистой системы при респираторных вирусных инфекциях

Осложнения со стороны сердечно-сосудистой системы при респираторных вирусных инфекциях

Автор: Ишмурзин Г. П., Серебрякова О. А., Сюзев К. Н., Долганова Д. А., Гайнуллина А. Х.

Журнал: Сибирский журнал клинической и экспериментальной медицины @cardiotomsk

Рубрика: Обзоры и лекции

Статья в выпуске: 4 т.37, 2022 года.

Бесплатный доступ

Несмотря на значительный прогресс в понимании патогенеза вирусных болезней и способов их лечения, один только вирус гриппа вызывает до 35 млн тяжелых случаев заболевания и 250-500 тыс. смертей ежегодно. Однако респираторные вирусы способны влиять не только на дыхательную систему, но и в том числе вызывать осложнения со стороны сердечно-сосудистой системы (ССС), такие как: острый коронарный синдром (ОКС), миокардиты и перикардиты, обострение хронической сердечной недостаточности (ХСН), острая сердечная недостаточность, тромбоэмболия легочной артерии и аритмии. В данном обзоре представлена информация о частоте встречаемости сердечно-сосудистых осложнений, возникших в ассоциации с перенесенными острыми респираторными вирусными инфекциями (новая коронавирусная инфекция, грипп, РС-инфекция, аденои риновирусные инфекции), механизмах влияния респираторных вирусов на ССС. Понимание данных механизмов позволит предвидеть возможные сердечнососудистые осложнения у пациентов с респираторными инфекциями, как можно раньше предпринять меры для быстрого их купирования, особенно при жизнеугрожающих состояниях.

Еще

Факторы риска сердечно-сосудистых заболеваний, covid-19, грипп, рс-вирус

Короткий адрес: https://sciup.org/149141451

IDR: 149141451   |   DOI: 10.29001/2073-8552-2022-37-4-31-37

Список литературы Осложнения со стороны сердечно-сосудистой системы при респираторных вирусных инфекциях

  • Flora G.D., Nayak M.K. A Brief review of cardiovascular diseases, associated risk factors and current treatment regimes. Curr. Pharm. Des. 2019;25(38):4063-4084. DOI: 10.2174/1381612825666190925 163827.
  • Khayyam-Nekouei Z., Neshatdoost H., Yousefy A., Sadeghi M., Man-shaee G. Psychological factors and coronary heart disease. ARYA Ath-eroscler. 2013;9(1):102-111.
  • Dhainaut J.-F., Claessens Y.-E., Janes J., Nelson D.R. Underlying disorders and their impact on the host response to infection. Clin. Infect. Dis. 2005;41(7):S481-S489. DOI: 10.1086/432001.
  • Elezkurtaj S., Greuel S., Ihlow J., Michaelis E. G., Bischoff P., Kunze C.A. et al. Causes of death and comorbidities in hospitalized patients with COVID-19. Sci. Rep. 2021;11(1):4263. DOI: 10.1038/s41598-021-82862-5.
  • Ketcham S.W., Bolig T.C., Molling D.J., Sjoding M.W., Flanders S.A., Prescott H.C. Causes and Circumstances of Death among Patients Hospitalized with COVID-19: A Retrospective Cohort Study. Ann. A. Thorac. Soc. 2021;18(6):1076-1079. DOI: 10.1513/Annal-sATS.202011-1381RL.
  • Gopinathannair R., Merchant F.M., Lakkireddy D.R., Etheridge S.P., Feigofsky S., Han J.K. et al. COVID-19 and cardiac arrhythmias: A global perspective on arrhythmia characteristics and management strategies. J. Interv. Card. Electrophysiol. 2020;59(2):329-336. DOI: 10.1007/ s10840-020-00789-9.
  • Wichmann D., Sperhake J.P., Lütgehetmann M., Steurer S., Edler C., Heinemann A. et al. Autopsy Findings and Venous Thromboembolism in Patients with COVID-19: A Prospective Cohort Study. Ann. Intern. Med. 2020;173(4):268-277. DOI: 10.7326/M20-2003.
  • Bellosta R., Luzzani L., Natalini G., Pegorer M.A., Attisani L., Cossu L.G. et al. Acute limb ischemia in patients with COVID-19 pneumonia. J. Vasc. Surg. 2020;72(6):1864-1872. DOI: 10.1016/j.jvs.2020.04.483.
  • Stefanini G.G., Montorfano M., Trabattoni D., Andreini D., Ferrante G., Ancona M. et al. ST-Elevation Myocardial infarction in patients with COVID-19: Clinical and angiographic outcomes. Circulation. 2020;141(25):2113—2116. DOI: 10.1161/CIRCULATIONA-HA.120.047525.
  • Daniels C.J., Rajpal S., Greenshields J.T., Rosenthal G. L., Chung E.H., Terrin M. et al. Prevalence of clinical and subclinical myocarditis in competitive athletes with recent SARS-CoV-2 Infection: Results from the big ten COVID-19 cardiac registry. JAMA Cardiol. 2021;6(9):1078-1087. DOI: 10.1001/jamacardio.2021.2065.
  • Puntmann V.O., Carerj M.L., Wieters I., Fahim M., Arendt C., Hoffmann J. et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(11):1265-1273. DOI: 10.1001/ja-macardio.2020.3557.
  • Guo T., Fan Y., Chen M., Wu X., Zhang L., He T. et al. Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19). JAMA Cardiol. 2020;5(7):811-818. DOI: 10.1001/jamacar-dio.2020.1017.
  • Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395(10229):1054-1062. DOI: 10.1016/S0140-6736(20)30566-3.
  • Goyal P., Choi J.J., Pinheiro L.C., Schenck E. J., Chen R., Jabri A. et al. Clinical characteristics of COVID-19 in New York City. N. Engl. J. Med. 2020;382(24):2372-2374. DOI: 10.1056/NEJMc2010419.
  • Buckley B.J.R., Harrison S.L., Fazio-Eynullayeva E., Underhill P., Lane D.A., Lip G.Y.H. Prevalence and clinical outcomes of myocarditis and pericarditis in 718,365 COVID-19 patients. Eur. J. Clin. Invest. 2021;51(11):e13679. DOI: 10.1111/eci.13679.
  • Pillarisetti J., Cheema M.S., Haloot J., Panday M., Badin A., Mehta A. et al. Cardiac complications of COVID-19: Incidence and outcomes. Indian. Heart J. 2022;74(3):170-177. DOI: 10.1016/j.ihj.2022.04.008.
  • Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J. et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020;323(11):1061-1069. DOI: 10.1001/jama.2020.1585.
  • Deng Q., Hu B., Zhang Y., Wang H., Zhou X., Hu W. et al. Suspected myocardial injury in patients with COVID-19: Evidence from front-line clinical observation in Wuhan, China. Int. J. Cardiol. 2020;311:116-121. DOI: 10.1016/j.ijcard.2020.03.087.
  • Malas M.B., Naazie I.N., Elsayed N., Mathlouthi A., Marmor R., Clary B. Thromboembolism risk of COVID-19 is high and associated with a higher risk of mortality: A systematic review and meta-analysis. EClinicalMedi-cine. 2020;29:100639. DOI: 10.1016/j.eclinm.2020.100639.
  • Kollias A., Kyriakoulis K.G., Lagou S., Kontopantelis E., Stergiou G.S., Syrigos K. Venous thromboembolism in COVID-19: A systematic review and meta-analysis. Vasc. Med. 2021;26(4):415-425. DOI: 10.1177/1358863X21995566.
  • Bristow M.R., Zisman L.S., Altman N.L., Gilbert E.M., Lowes B.D., Mi-nobe A. et al. Dynamic regulation of SARS-Cov-2 binding and cell entry mechanisms in remodeled human ventricular myocardium. JACC Basic. Transl. Sci. 2020;5(9):871-883. DOI: 10.1016/j.jacbts.2020.06.007.
  • Sharma A., Garcia G. Jr., Wang Y., Plummer J. T., Morizono K., Arumu-gaswami V. et al. Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection. Cell Rep. Med. 2020;1(4):100052. DOI: 10.1016/j.xcrm.2020.100052.
  • Lindner D., Fitzek A., Brauninger H., Aleshcheva G., Edler C., Meissner K. et al. Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol. 2020;5(11):1281-1285. DOI:10.1001/jamacardio.2020.3551.
  • Kogan E., Berezovskiy Y., Blagova O., Kukleva A., Semyonova L., Gretsov E. et al. Morphologically, immunohistochemically and PCR proven lymphocytic viral peri-, endo-, myocarditis in patients with fatal COVID-19. Diagn. Pathol. 2022;17(1):31. DOI: 10.1186/s13000-022-01207-6.
  • Basso C., Leone O., Rizzo S., De Gaspari M., van der Wal A.C., Aub-ry M.C. et al. Pathological features of COVID-19-associated myocardial injury: a multicentre cardiovascular pathology study. Eur. Heart J. 2020;41(39):3827-3835. DOI: 10.1093/eurheartj/ehaa664.
  • Dolhnikoff M., Ferreira Ferranti J., de Almeida Monteiro R.A., Duarte-Neto A.N., Soares Gomes-Gouvea M., Viu Degaspare N. et al. SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome. Lancet ChildAdolesc. Health. 2020;4(10):790-794. DOI: 10.1016/S2352-4642(20)30257-1.
  • Prabhu S.D. Cytokine-induced modulation of cardiac function. Circ. Res. 2004;95(12):1140-1153. DOI: 10.1161/01.RES.0000150734.79804.92.
  • McClenaghan C., Hanson A., Lee S.J., Nichols C.G. Coronavirus proteins as ion channels: Current and potential research. Front. Immunol. 2020;11:573339. DOI: 10.3389/fimmu.2020.573339.
  • Kwong J.C., Schwartz K.L., Campitelli M.A., Chung H., Crowcroft N.S., Karnauchow T. et al. Acute myocardial infarction after laboratory-confirmed influenza infection. N. Engl. J. Med. 2018;378(4):345-353. DOI: 10.1056/NEJMoa1702090.
  • Nguyen J.L., Yang W., Ito K., Matte T.D., Shaman J., Kinney P.L. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2016;1(3):274-281. DOI: 10.1001/jamacardio.2016.0433.
  • Reichert T.A., Simonsen L., Sharma A., Pardo S.A., Fedson D.S., Miller M.A. Influenza and the winter increase in mortality in the United States, 1959-1999. Am. J. Epidemiol. 2004;160(5):492-502. DOI:10.1093/aje/ kwh227.
  • Qi L., Li Q., Ding X.B., Gao Y., Ling H., Liu T. et al. Mortality burden from seasonal influenza in Chongqing, China, 2012-2018. Hum. Vaccin. Immu-nother. 2020;16(7):1668-1674. DOI: 10.1080/21645515.2019.1693721.
  • Kumar K., Guirgis M., Zieroth S., Lo E., Menkis A.H., Arora R.C. et al. Influenza myocarditis and myositis: case presentation and review of the literature. Can. J. Cardiol. 2011;27(4):514-522. DOI: 10.1016/j. cjca.2011.03.005.
  • Ukimura A., Satomi H., Ooi Y., Kanzaki Y. Myocarditis Associated with Influenza A H1N1pdm2009. Influenza Res. Treat. 2012;2012:351979. DOI: 10.1155/2012/351979.
  • Dolader P., Balcells J., Gran F. Influenza myocarditis in paediatric patients. Cardiol. Young. 2021;1-3. DOI: 10.1017/S1047951121004777.
  • Purdy A., Ido F., Sterner S., Tesoriero E., Matthews T., Singh A. Myocarditis in COVID-19 presenting with cardiogenic shock: A case series. Eur. Heart J. Case Rep. 2021;5(2):ytab028. DOI: 10.1093/ehjcr/ytab028.
  • Madjid M., Connolly A.T., Nabutovsky Y., Safavi-Naeini P., Razavi M., Miller C.C. Effect of high influenza activity on risk of ventricular arrhythmias requiring therapy in patients with implantable cardiac defibrillators and cardiac resynchronization therapy defibrillators. Am. J. Cardiol. 2019;124(1):44-50. DOI: 10.1016/j.amjcard.2019.04.011.
  • Cheng W.L., Lin C.S. Transient atrioventricular block as a complication of influenza a virus: A case report. J. Acute Med. 2021;11(3):102-104. DOI: 10.6705/jjacme.202109_11(3).0004.
  • Rivera-Guzmán N., Del Olmo-Arroyo F., Robles-Arías C.M., Rodrí-guez-Cintrón W. Transient AV block as a hemodynamic complication of the influenza a virus: A case report. P.R. Health Sci. J. 2016;35(3):173-175.
  • Beinart R., Morganti K., Ruskin J., Mela T. H1N1 influenza A virus induced atrioventricular block. J. Cardiovasc. Electrophysiol. 2011;22(6):711-713. DOI: 10.1111/j.1540-8167.2010.01931.x.
  • Estabragh Z.R., Mamas M.A. The cardiovascular manifestations of influenza: a systematic review. Int. J. Cardiol. 2013;167(6):2397-2403. DOI: 10.1016/j.ijcard.2013.01.274.
  • Goshua G., Pine A.B., Meizlish M.L., Chang C.H., Zhang H., Bahel P. et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. 2020;7(8):e575-e582. DOI: 10.1016/S2352-3026(20)30216-7.
  • Van Wissen M., Keller T.T., van Gorp E.C., Gerdes V.E., Meijers J.C., van Doornum G.J. et al. Acute respiratory tract infection leads to procoagulant changes in human subjects. J. Thromb. Haemost. 2011;9(7):1432-1434. DOI: 10.1111/j.1538-7836.2011.04340.x
  • Suo J., Zhao L., Wang J., Zhu Z., Zhang H., Gao R. Influenza virus aggravates the ox-LDL-induced apoptosis of human endothelial cells via promoting p53 signaling. J. Med. Virol. 2015;87(7):1113-1123. DOI: 10.1002/jmv.24166.
  • Fang Y.A., Chen C.I., Liu J.C., Sung L.C. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: A population-based cohort study. Acta Cardiol. Sin. 2016;32(3):290-298. DOI: 10.6515/acs20150424l.
  • Sung L.C., Chen C.I., Fang Y.A., Lai C.H., Hsu Y.P., Cheng T.H. et al. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: A population-based cohort study. Vaccine. 2014;32(30):3843-3849. DOI: 10.1016/j.vaccine.2014.04.064.
  • Yedlapati S.H., Khan S.U., Talluri S., Lone A.N., Khan M.Z., Khan M.S. et al. Effects of influenza vaccine on mortality and cardiovascular outcomes in patients with cardiovascular disease: A systematic review and meta-analysis. J. Am. Heart Assoc. 2021;10(6):e019636. DOI: 10.1161/ JAHA.120.019636.
  • Volling C., Hassan K., Mazzulli T., Green K., Al-Den A., Hunter P. et al. Respiratory syncytial virus infection-associated hospitalization in adults: A retrospective cohort study. BMC Infect. Dis. 2014;14:665. DOI: 10.1186/s12879-014-0665-2.
  • Walsh E.E., Peterson D.R., Falsey A.R. Risk factors for severe respiratory syncytial virus infection in elderly persons. J. Infect. Dis. 2004;189(2):233-238. DOI: 10.1086/380907.
  • Dowell S.F., Anderson L.J., Gary H.E. Jr., Erdman D.D., Plouffe J.F., File T.M. et al. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J. Infect. Dis. 1996;174(3):456-462. DOI: 10.1093/infdis/174.3.456.
  • Chuaychoo B., Ngamwongwan S., Kaewnaphan B., Athipanyasilp N., Horthongkham N., Kantakamalakul W. et al. Clinical manifestations and outcomes of respiratory syncytial virus infection in adult hospitalized patients. J. Clin. Virol. 2019;117:103-108. DOI: 10.1016/j.jcv.2019.07.001.
  • Lee N., Lui G.C., Wong K.T., Li T.C., Tse E.C., Chan J.Y. et al. High morbidity and mortality in adults hospitalized for respiratory syncytial virus infections. Clin. Infect. Dis. 2013;57(8):1069-1077. DOI: 10.1093/cid/ cit471.
  • Cebeci B., Oguz D., Ataoglu E., Elevli M., Yolcu C. Rhinovirus as a rare cause of acute onset dilated cardiomyopathy due to myocarditis in a newborn: case report and review of the literature. Turk. J. Pediatr. 2022;64(1):142-146. DOI: 10.24953/turkjped.2020.3664.
  • Chow J., Murphy J., Subedi A., Jyothidasan A. Rhinovirus-associated dilated cardiomyopathy. IDCases. 2020;19:e00702. DOI: 10.1016/j. idcr.2020.e00702.
  • Choi M.J., Song J.Y., Yang T.U., Jeon J.H., Noh J.Y., Hong K.W. et al. Acute myopericarditis caused by human Metapneumovirus. Infect. Chemother. 2016;48(1):36-40. DOI: 10.3947/ic.2016.48.1.36.
  • Romero-Gómez M.P., Guereta L., Pareja-Grande J., Martínez-Alarcón J., Casas I., Ruiz-Carrascoso G. et al. Myocarditis caused by human parainfluenza virus in an immunocompetent child initially associated with 2009 influenza A (H1N1) virus. J. Clin. Microbiol. 2011;49(5):2072-2073. DOI: 10.1128/JCM.02638-10.
Еще
Статья научная
SciUp 2024 © 2024 ©